APA

Müller A., Krämer S. D., Meletta R., Beck K., Selivanova S. V., Rancic Z., Kaufmann P. A., Vos B., Meding J., Stellfeld T., Heinrich T. K., Bauser M., Hütter J., Dinkelborg L. M., Schibli R. & Ametamey S. M. (20150302). Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. : Nuclear medicine and biology.

Chicago

Müller Adrienne, Krämer Stefanie D, Meletta Romana, Beck Katharina, Selivanova Svetlana V, Rancic Zoran, Kaufmann Philipp A, Vos Bernhard, Meding Jörg, Stellfeld Timo, Heinrich Tobias K, Bauser Marcus, Hütter Joachim, Dinkelborg Ludger M, Schibli Roger and Ametamey Simon M. 20150302. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. : Nuclear medicine and biology.

Harvard

Müller A., Krämer S. D., Meletta R., Beck K., Selivanova S. V., Rancic Z., Kaufmann P. A., Vos B., Meding J., Stellfeld T., Heinrich T. K., Bauser M., Hütter J., Dinkelborg L. M., Schibli R. and Ametamey S. M. (20150302). Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. : Nuclear medicine and biology.

MLA

Müller Adrienne, Krämer Stefanie D, Meletta Romana, Beck Katharina, Selivanova Svetlana V, Rancic Zoran, Kaufmann Philipp A, Vos Bernhard, Meding Jörg, Stellfeld Timo, Heinrich Tobias K, Bauser Marcus, Hütter Joachim, Dinkelborg Ludger M, Schibli Roger and Ametamey Simon M. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. : Nuclear medicine and biology. 20150302.